Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun;31(3):418-23.
doi: 10.1007/s10545-008-0830-0. Epub 2008 Apr 4.

Reduction in bone mineral density in glycogenosis type III may be due to a mixed muscle and bone deficit

H R Mundy  1 , J E Williams, P J Lee, M S Fewtrell
Affiliations

Reduction in bone mineral density in glycogenosis type III may be due to a mixed muscle and bone deficit

H R Mundy et al. J Inherit Metab Dis. 2008 Jun.

Abstract

Glycogen storage disease type III (GSD III; OMIM 232400) is an autosomal recessive deficiency of the glycogen debrancher enzyme, amylo-1,6-glucosidase (EC 3.2.1.33). Patients with other hepatic glycogenoses are known to have reduced bone mineral content (BMC) and to be at consequent risk of fractures. They have key metabolic differences from GSD III patients, however. This study examines bone density and metabolism in 15 GSD III patients (6 female) from childhood to adulthood (aged 10-34 years). The results demonstrate that patients with GSD III have low bone mass at all skeletal sites compared with healthy individuals of the same age and sex, with a significant proportion (40-64%) having BMD > 2 standard deviations below the mean for whole body and lumbar spine. The deficiency seems to be attributable to a mixed muscle andbone deficit. Lower bone mass was found at all sites for GSD IIIa patients (combined liver and muscle defect) compared with GSD IIIb patients (liver only defect).

Conclusion: Patients with GSD III have significantly abnormal bone mass, placing them at increased risk of potential fracture. The underlying mechanism is probably multifactorial with contributions from abnormal muscle physiology, abnormal metabolic milieu and altered nutrition affecting micronutrient intake. Therapies need to address all these factors to be successful.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Gene. 1997 Sep 15;197(1-2):389-98 - PubMed
    1. Am J Clin Nutr. 2003 Jan;77(1):257-65 - PubMed
    1. J Pediatr. 2003 Jul;143(1):81-8 - PubMed
    1. J Bone Miner Res. 1999 May;14(5):810-20 - PubMed
    1. Eur J Pediatr. 1995 Jun;154(6):483-7 - PubMed

Substances

LinkOut - more resources